Metraipolis › archive › dc_3fb8efe47c35

Mycophenolate mofetil versus azathioprine as a first-line treatment for autoimmune hepatitis: a comparative systematic review and meta-analysis — Europe PMC PMID:40846917

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40846917
DOI
10.1186/s12876-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-10T10:55:26.045Z
SHA-256 of the archived text
54705ced5cad1a92b1496024c8f89dab000c7d5b9112c92288bd2233da54a2e4
Stable URL of this page
https://metraipolis.com/documento/dc_3fb8efe47c35

How to cite

Mycophenolate mofetil versus azathioprine as a first-line treatment for autoimmune hepatitis: a comparative systematic review and meta-analysis — Europe PMC PMID:40846917 — Europe PMC (en), https://europepmc.org/article/MED/40846917 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fb8efe47c35 (Metraipolis archive dc_3fb8efe47c35, sha256 54705ced5cad1a92b1496024c8f89dab000c7d5b9112c92288bd2233da54a2e4)
BibTeX
@misc{dc3fb8efe47c35,
  title = {Mycophenolate mofetil versus azathioprine as a first-line treatment for autoimmune hepatitis: a comparative systematic review and meta-analysis — Europe PMC PMID:40846917},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40846917},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fb8efe47c35; sha256 54705ced5cad1a92b1496024c8f89dab000c7d5b9112c92288bd2233da54a2e4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40846917. Agents can read the archived copy with the MCP tool read_document.